Tapentadol is a relativly new opioid that was approved by the FDA on June 22, 2009. It is a schedule II drug in the US, and is currently sold in doses of 50, 75, and 100mg under the trade name Nucynta. Since this drug is so new, it is not very well known. Therefore, I am posting this report to...